ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 97 filers reported holding ALBIREO PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,147,000 | -23.2% | 57,758 | +15.3% | 0.01% | +22.2% |
| Q1 2022 | $1,494,000 | -0.2% | 50,085 | -22.1% | 0.01% | +12.5% |
| Q4 2021 | $1,497,000 | +14.7% | 64,288 | +53.7% | 0.01% | -11.1% |
| Q3 2021 | $1,305,000 | +22.7% | 41,818 | +38.2% | 0.01% | +28.6% |
| Q2 2021 | $1,064,000 | -38.8% | 30,253 | -38.7% | 0.01% | -41.7% |
| Q1 2021 | $1,739,000 | +514.5% | 49,328 | +553.1% | 0.01% | +300.0% |
| Q4 2020 | $283,000 | – | 7,553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |